1801.HK
Price:
$93.55
Market Cap:
$139.05B
Innovent Biologics, Inc., established in 2011 and headquartered in Suzhou, People's Republic of China, functions as a leading biopharmaceutical enterprise. The company is dedicated to the comprehensive lifecycle of antibody drug candidates, encompassing their discovery, development, and eventual manufacturing. Its therapeutic focus spans critical areas such as oncology, ophthalmology, immunology, and metabolic diseases. A key product in its portfolio is Tyvyt (sintilimab), an anti-PD-1 monoclonal antibody utilized in the treatment of various cancers, including Hodgkin's lymphoma and esophageal carcinoma. Innovent's commercialized offerings also include Byvasda, employed for several malignant...[Read more]
Industry
Biotechnology
IPO Date
2018-10-31
Stock Exchange
HKSE
Ticker
1801.HK
According to Innovent Biologics, Inc.’s latest financial reports and current stock price. The company's current ROE is 6.06%. This represents a change of 74.27% compared to the average of 3.48% of the last 4 quarters.
The mean historical ROE of Innovent Biologics, Inc. over the last ten years is -17.12%. The current 6.06% ROE has changed -135.39% with respect to the historical average. Over the past ten years (40 quarters), 1801.HK's ROE was at its highest in in the December 2017 quarter at 18.29%. The ROE was at its lowest in in the December 2018 quarter at -138.65%.
Average
-17.12%
Median
-9.79%
Minimum
-137.60%
Maximum
36.43%
Discovering the peaks and valleys of Innovent Biologics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 132.28%
Maximum Annual ROE = 36.43%
Minimum Annual Increase = -682.39%
Minimum Annual ROE = -137.60%
| Year | ROE | Change |
|---|---|---|
| 2025 | 4.20% | -682.39% |
| 2024 | -0.72% | -91.21% |
| 2023 | -8.21% | -59.60% |
| 2022 | -20.31% | -23.11% |
| 2021 | -26.41% | 132.28% |
| 2020 | -11.37% | -68.55% |
| 2019 | -36.16% | -73.72% |
| 2018 | -137.60% | -575.34% |
| 2017 | 28.95% | -20.55% |
The current ROE of Innovent Biologics, Inc. (1801.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.58%
5-year avg
-10.29%
10-year avg
-17.12%
Innovent Biologics, Inc.’s ROE is less than WuXi Biologics (Cayman) Inc. (10.51%), less than Sino Biopharmaceutical Limited (7.56%), greater than Akeso, Inc. (-10.86%), less than 3SBio Inc. (30.16%), less than Pharmaron Beijing Co., Ltd. (10.96%), greater than Shanghai Junshi Biosciences Co., Ltd. (-7.32%), greater than TransThera Sciences (Nanjing). Inc. (-40.84%), less than JD Health International Inc. (10.15%), less than Shanghai Henlius Biotech, Inc. (20.41%), less than RemeGen Co., Ltd. (128.12%),
| Company | ROE | Market cap |
|---|---|---|
| 10.51% | $194.75B | |
| 7.56% | $93.53B | |
| -10.86% | $83.07B | |
| 30.16% | $38.61B | |
| 10.96% | $75.16B | |
| -7.32% | $23.38B | |
| -40.84% | $3.72B | |
| 10.15% | $111.55B | |
| 20.41% | $34.24B | |
| 128.12% | $40.81B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Innovent Biologics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Innovent Biologics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Innovent Biologics, Inc.'s ROE?
How is the ROE calculated for Innovent Biologics, Inc. (1801.HK)?
What is the highest ROE for Innovent Biologics, Inc. (1801.HK)?
What is the 3-year average ROE for Innovent Biologics, Inc. (1801.HK)?
What is the 5-year average ROE for Innovent Biologics, Inc. (1801.HK)?
How does the current ROE for Innovent Biologics, Inc. (1801.HK) compare to its historical average?